Charles Schwab’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-217,621
| Closed | -$186K | – | 3568 |
|
|
2022
Q2 | $186K | Sell |
217,621
-74,256
| -25% | -$63.5K | ﹤0.01% | 3244 |
|
|
2022
Q1 | $1.61M | Sell |
291,877
-13,389
| -4% | -$73.8K | ﹤0.01% | 2718 |
|
|
2021
Q4 | $2.96M | Buy |
305,266
+6,144
| +2% | +$59.5K | ﹤0.01% | 2572 |
|
|
2021
Q3 | $5.35M | Sell |
299,122
-6,925
| -2% | -$124K | ﹤0.01% | 2341 |
|
|
2021
Q2 | $7.47M | Buy |
306,047
+33,256
| +12% | +$812K | ﹤0.01% | 2153 |
|
|
2021
Q1 | $7.23M | Buy |
272,791
+29,866
| +12% | +$791K | ﹤0.01% | 2120 |
|
|
2020
Q4 | $1.84M | Buy |
242,925
+7,303
| +3% | +$55.4K | ﹤0.01% | 2608 |
|
|
2020
Q3 | $1.18M | Buy |
235,622
+4,967
| +2% | +$24.9K | ﹤0.01% | 2636 |
|
|
2020
Q2 | $1.38M | Buy |
230,655
+17,219
| +8% | +$103K | ﹤0.01% | 2544 |
|
|
2020
Q1 | $950K | Buy |
213,436
+2,943
| +1% | +$13.1K | ﹤0.01% | 2503 |
|
|
2019
Q4 | $2M | Buy |
210,493
+3,499
| +2% | +$33.2K | ﹤0.01% | 2415 |
|
|
2019
Q3 | $1.63M | Buy |
206,994
+90,773
| +78% | +$713K | ﹤0.01% | 2452 |
|
|
2019
Q2 | $1.83M | Buy |
116,221
+11,506
| +11% | +$181K | ﹤0.01% | 2398 |
|
|
2019
Q1 | $1.9M | Buy |
104,715
+42,802
| +69% | +$775K | ﹤0.01% | 2378 |
|
|
2018
Q4 | $996K | Sell |
61,913
-740
| -1% | -$11.9K | ﹤0.01% | 2538 |
|
|
2018
Q3 | $1.5M | Buy |
+62,653
| New | +$1.5M | ﹤0.01% | 2511 |
|